Lensar outlines 46%-49% gross margin forecast for 2026 as it restarts growth after Alcon deal termination
Source: SeekingAlpha
2026-03-31 14:33:06 ET
More on LENSAR
- LENSAR, Inc. (LNSR) Q4 2025 Earnings Call Transcript
- Alcon And LENSAR: Why The Broken Merger Creates Two Different Buy Cases
- LENSAR GAAP EPS of -$0.12 misses by $0.05, revenue of $16.03M misses by $4.27M
- Quant snapshot: J. Jill, AngioDynamics leads strong buys as INmune Bio, Terrestrial Energy lag
- Seeking Alpha’s Quant Rating on LENSAR
Read the full article on Seeking Alpha
For further details see:
Lensar outlines 46%–49% gross margin forecast for 2026 as it restarts growth after Alcon deal termination
LENSAR Inc.
NASDAQ: LNSR
LNSR Trading
-0.36% G/L:
$5.58 Last:
12,643 Volume:
$5.56 Open:
LNSR Latest News
LNSR Stock Data
$149,247,102
4,061,146
9.37%
26
N/A
Medical Equipment & Supplies
Healthcare
US
Orlando
